Page 54 - Amgen News Today

Though more than half of the stocks that make up the Dow Jones Industrial Average were rising on Friday, the bulk of its gains were driven by Amgen and Apple.…

Apple reports better-than-estimated earnings and expands its buyback program by $110 billion, Amgen ‘very encouraged’ by preliminary data from a trial of a…

Amgen earnings beat estimates, and MariTide's promising Phase 2 results suggest significant differentiation from competitors.

Futures for Canadas main stock index inched up on Friday, lifted by positive corporate updates, as investors await a key jobs report from the U.S. Labor Department later in the day to gauge the...

(CTN News) - In a statement on Thursday, Amgen said it will stop developing an experimental weight loss pill in favor of its injectable..................

-U.S. drugmaker Amgens shares jumped 14% premarket on Friday as the company said it was encouraged by interim trial data on its experimental obesity drug, denting rival stocks but... -May 03, 2024 at 06:16 am EDT - MarketScreener

Amgen shares surged more than 14% in late trade Thursday after topping Q1 earnings estimates and providing a positive update on its injectable weigh-loss drug MariTide.

First Horizon Advisors Inc. decreased its stake in Amgen Inc. (NASDAQ:AMGN – Free Report) by 2.4% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 41,299 shares of the medical research company’s stock after selling 995 shares during the period. First […]

Investegate announcements from Top Ten Equity Holdings and Exposures

The Business Post keeps you up to date with bite-size servings of the latest in business, tech and current affairs